Immunome Newsroom

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireDec 3 07:26

Express News | Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 3 07:26

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 27 21:00

Immunome President Acquires 24% More Stock

Simply Wall StNov 27 18:19

Immunome Insider Bought Shares Worth $962,181, According to a Recent SEC Filing

MT NewswiresNov 25 22:05

Immunome CEO Clay Siegall Acquires $962,181 in Company Stock

InvestingNov 25 21:44

Express News | Immunome Inc Files for Resale of up to 1.8 Mln Shares by the Selling Stockholder - SEC Filing

BreakingsNov 23 05:02

Immunome (IMNM) Receives a Buy From J.P. Morgan

TipRanksNov 19 20:08 · Ratings

Immunome Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.

BenzingaNov 16 01:52

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Futu NewsNov 14 22:33 · Ratings

Immunome Is Maintained at Overweight by Piper Sandler

Dow JonesNov 14 20:35 · Ratings

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $21

Futu NewsNov 14 20:31 · Ratings

Immunome Analyst Ratings

BenzingaNov 14 20:24 · Ratings

Express News | Immunome Inc : Piper Sandler Cuts Target Price to $21 From $23

BreakingsNov 14 14:46

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsNov 14 09:32 · Ratings

Promising Growth Potential for Immunome: Buy Rating Backed by Strategic Acquisitions and Innovative Pipeline

TipRanksNov 14 09:15 · Ratings

Immunome, Inc GAAP EPS of -$0.78 Misses by $0.21

Seeking AlphaNov 14 07:06

Immunome, Inc. (IMNM) Reports Q3 Loss, Misses Revenue Estimates

Zacks Nov 14 05:31

Immunome | 10-Q: Q3 2024 Earnings Report

SECNov 14 05:16 · Announcements

Immunome | 8-K: Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update

SECNov 14 05:12